Kevin Capp
Family Medicine · Erie, PANPI 1588800155
Payments from drug & device makers
Across 422 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$989
- GSK$874
- Novo Nordisk$870
- Pfizer$534
- AstraZeneca$358
- Astellas Pharma US Inc$317
- plus $2K from 30 others
What the payments were for
- Food & beverage$6,288100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 71 | $989 |
| GSK | 82 | $874 |
| Novo Nordisk | 58 | $870 |
| Pfizer | 34 | $534 |
| AstraZeneca | 21 | $358 |
| Astellas Pharma US Inc | 17 | $317 |
| Boehringer Ingelheim | 20 | $292 |
| AbbVie | 11 | $258 |
| Nevro Corp. | 6 | $230 |
| Exact Sciences | 9 | $204 |
| Amarin Pharma, Inc. | 11 | $165 |
| Johnson & Johnson | 10 | $126 |
| Merck | 13 | $118 |
| Abbott | 7 | $110 |
| Novartis | 7 | $99 |
| Daiichi Sankyo Inc. | 5 | $90 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $83 |
| Biohaven Pharmaceuticals, Inc. | 5 | $83 |
| Viatris Specialty LLC | 3 | $63 |
| E.r. Squibb & Sons, L.L.C. | 4 | $59 |
| Boston Scientific | 1 | $48 |
| Bayer | 3 | $48 |
| Currax Pharmaceuticals LLC | 3 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Philips North America LLC | 2 | $28 |
| Amgen | 2 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| GRT US Holding, Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $10 |
| Bardy Diagnostics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$125
How this compares
$6,303 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $104,242 |
| JardianceEmpagliflozin | 126 | $96,848 |
| EliquisApixaban | 91 | $87,739 |
| TrulicityDulaglutide | 47 | $51,260 |
| XifaxanRifaximin | 11 | $40,974 |
| XareltoRivaroxaban | 47 | $40,159 |
| RybelsusSemaglutide | 39 | $39,654 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $38,403 |
| JanuviaSitagliptin Phosphate | 27 | $30,698 |
| TradjentaLinagliptin | 16 | $18,266 |
| FarxigaDapagliflozin Propanediol | 11 | $17,604 |
| MounjaroTirzepatide | 13 | $13,851 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $12,388 |
| MyrbetriqMirabegron | 13 | $9,590 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $9,571 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $870 | $143,896133 claims |
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat | $292 | $122,363157 claims |
| PfizerEliquis, Premarin | $534 | $89,586105 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $989 | $65,11160 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $874 | $47,97477 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $29 | $40,97411 claims |
| Johnson & JohnsonXarelto | $126 | $40,15947 claims |
| MerckJanuvia | $118 | $30,69827 claims |
| AstraZenecaFarxiga | $358 | $17,60411 claims |
| Astellas Pharma US IncMyrbetriq | $317 | $9,59013 claims |
| AbbVieLinzess | $258 | $9,36014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Erie
- Bruce GebhardtErie$2.1M
- Bradley FoxErie$1.7M
- Jack YakishErie$86K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.